About Humm
Humm is a company based in San Francisco (United States) founded in 2019 by Iain Cameron McIntyre and Tim Fiori. Humm has raised $2.6 million across 1 funding round from investors including Berkeley SkyDeck, BlueYard Capital and CRCM Ventures. Humm operates in a competitive market with competitors including Noctrix Health, Emotiv, Neurovalens, Livescribe and Zynex, among others.
- Headquarter San Francisco, United States
- Founders Iain Cameron McIntyre, Tim Fiori
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.6 M (USD)
in 1 rounds
-
Latest Funding Round
$2.6 M (USD), Seed
Dec 18, 2019
-
Investors
Berkeley SkyDeck
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Humm
Humm has successfully raised a total of $2.6M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.6 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Humm
Humm has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Berkeley SkyDeck, BlueYard Capital and CRCM Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BlueYard Capital is engaged in early-stage technology investments.
|
Locked | Locked | Locked | |
|
Startups are accelerated and incubated across diverse industries.
|
Locked | Locked | Locked | |
|
Investments are directed toward seed-stage startups by CRCM Ventures.
|
Locked | Locked | Locked |
Investor details for Humm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Humm
Investment portfolio details for Humm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Humm
Detailed financials for Humm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Humm Comparisons
Peer comparison for Humm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Humm
Humm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noctrix Health, Emotiv, Neurovalens, Livescribe and Zynex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable therapeutic devices for neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of wireless EEG headsets and software solutions
|
|
| Locked | Locked | Locked |
A headset-like device for obesity treatment is developed by Neurovalens.
|
|
| Locked | Locked | Locked |
Provider of smartpens and mobile computing platforms
|
|
| Locked | Locked | Locked |
Non-invasive electrotherapy and stroke rehabilitation devices are developed by Zynex.
|
|
| Locked | Locked | Locked |
Assistive technology is developed for impaired executive brain functions.
|
Detailed competitors of Humm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Humm
Complete news archive for Humm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Humm
Humm was founded in 2019.
Humm is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Iain Cameron McIntyre is the current CEO of Humm. They have also founded this company.
Humm is a funded company, having raised a total of $2.6M across 1 funding round to date.
Humm was founded in 2019 in San Francisco, United States, within the health technology sector. A wearable patch is produced by the company for non-invasive brain stimulation. The device is positioned on the forehead to support mental health functions, including memory retention and concentration levels. Operations focus on device development and distribution for cognitive enhancement applications.
Humm's top competitors include Emotiv, Neurovalens and Zynex.
Humm has 3 investors. Key investors include Berkeley SkyDeck, BlueYard Capital, and CRCM Ventures.